The Goldman Sachs Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday morning, MarketBeat ...
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...
17h
Zacks Investment Research on MSNGEHC Stock May Gain as Genesis Portfolio Expands Cloud OfferingsGE HealthCare Technologies Inc. GEHC has recently unveiled the Genesis portfolio, a portfolio of cloud enterprise imaging ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...
21h
Fintel on MSNGoldman Sachs Upgrades GE HealthCare Technologies (GEHC)Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...
Goldman Sachs upgraded GE HealthCare (GEHC) to Buy from Neutral with a price target of $100, up from $85. The firm’s confidence in the outlook ...
Shares of GE HealthCare Technologies Inc. GEHC slid 1.41% to $85.36 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results